Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Dow
QuintilesIMS
Julphar
Chubb
Covington
Baxter
Colorcon
Chinese Patent Office
US Department of Justice

Generated: January 16, 2018

DrugPatentWatch Database Preview

Precision Dermat Company Profile

« Back to Dashboard

What is the competitive landscape for PRECISION DERMAT, and when can generic versions of PRECISION DERMAT drugs launch?

PRECISION DERMAT has eight approved drugs.

There are three US patents protecting PRECISION DERMAT drugs on PRECISION DERMAT drugs in the past three years.

There are twenty-eight patent family members on PRECISION DERMAT drugs in twenty-two countries and eleven supplementary protection certificates in ten countries.

Summary for Precision Dermat
International Patents:28
US Patents:3
Tradenames:4
Ingredients:3
NDAs:8

Drugs and US Patents for Precision Dermat

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Precision Dermat LOCOID hydrocortisone butyrate LOTION;TOPICAL 022076-001 May 18, 2007 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Precision Dermat LOCOID hydrocortisone butyrate OINTMENT;TOPICAL 018652-001 Oct 29, 1982 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Precision Dermat MINOCIN minocycline hydrochloride CAPSULE;ORAL 050649-002 May 31, 1990 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Precision Dermat MINOCIN minocycline hydrochloride SUSPENSION;ORAL 050445-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Precision Dermat LOCOID LIPOCREAM hydrocortisone butyrate CREAM;TOPICAL 020769-001 Sep 8, 1997 AB2 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Precision Dermat MINOCIN minocycline hydrochloride CAPSULE;ORAL 050649-003 Feb 12, 2001 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Precision Dermat CLINDAGEL clindamycin phosphate GEL;TOPICAL 050782-001 Nov 27, 2000 BT RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Precision Dermat LOCOID hydrocortisone butyrate CREAM;TOPICAL 018514-001 Mar 31, 1982 AB1 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Precision Dermat LOCOID hydrocortisone butyrate LOTION;TOPICAL 022076-001 May 18, 2007 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Precision Dermat MINOCIN minocycline hydrochloride CAPSULE;ORAL 050649-001 May 31, 1990 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for PRECISION DERMAT drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Lotion 0.1% ➤ Subscribe 8/31/2016
➤ Subscribe Cream 0.1% ➤ Subscribe 6/28/2010
Premature patent expirations for PRECISION DERMAT

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
➤ Subscribe ➤ Subscribe

Non-Orange Book US Patents for Precision Dermat

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,517,847 Topical gel delivery system ➤ Subscribe
8,389,502 Stabilized steroid composition and method for its preparation ➤ Subscribe
8,546,364 Stabilized steroid composition and method for its preparation ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Precision Dermat Drugs

Supplementary Protection Certificates for Precision Dermat Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2013 00053 Denmark ➤ Subscribe PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
13/044 Ireland ➤ Subscribe PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
00617 Netherlands ➤ Subscribe PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
4 Finland ➤ Subscribe
90049-3 Sweden ➤ Subscribe PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322
C/GB10/012 United Kingdom ➤ Subscribe PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
401 Luxembourg ➤ Subscribe PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
2013025 Lithuania ➤ Subscribe PRODUCT NAME: CLINFAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
2013025,C1304992 Lithuania ➤ Subscribe PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
C0038 France ➤ Subscribe PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
McKinsey
Accenture
Julphar
US Army
Express Scripts
Merck
McKesson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot